By focusing on this emerging area of study, this review reveals promising new developments in the pathogenesis and treatment of depression, emphasizing the novel concept that balancing our internal microbiome and body clock could be key to effectively managing this condition. The gene discussed is CLOCK; the disease is depressive symptom measurement.